Normal
0
false
false
false
EN-US
X-NONE
AR-SA
MicrosoftInternetExplorer4
Background: It has been
suggested that Q/R
192 polymorphism of
paraoxonase1 (PON1) and 5A/6A
polymorphism of matrix metalloproteinase-3 (MMP-3) might be associated with the
predisposition to coronary artery disease (CAD). Therefore to investigate the significance of these polymorphisms in the
pathogenesis of CAD we performed an association
study of the polymorphisms with CAD and the
number of diseased vessels in patients with CAD.
Methods: We studied
the human PON1 and MMP3 gene polymorphisms in patients with CAD by polymerase chain reaction/ restriction
fragment length polymorphism (PCR/RFLP). These
polymorphisms were determined in 129 CAD patients and 115 control subjects who underwent
coronary angiography. CAD was defined
as the presence of one or more stenoses>50% in at least one major coronary artery and subjects with <10% stenosis served as controls.
Results: The
frequencies of the PON1
192 RR genotype and MMP-3 6A6A genotype were increased among CAD patients compared with controls (p<0.05 and p<0.001 respectively). The combined
genotypes of RR/6A6A had significantly higher
frequency in the CAD patients compared with subjects
who possess neither the MMP-3 6A6A nor the
PON1 RR genotype (p<0.001) and finally in the study of
relationship between genotypes and severity of disease, distribution of PON1 192 and MMP-3 5A6A genotypes were not associated
with the number of diseased vessels (p>0.05).
Conclusion: The combined PON1
192 and MMP-3
5A6A polymorphisms are associated with CAD but don't have any effect on the number of
diseased vessels.
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |